水溶性二甲基三硫醚作为高致死性氰化物中毒解毒剂的评估:大型猪模型研究
本研究在麻醉猪氰化物中毒模型(呼吸停止后5分钟给药)中评估肌注水溶性二甲基三硫醚(DMTS)的短期和长期疗效。DMTS组(n=11)生存率90%,生理盐水对照组(n=10)为30%(p=0.0034)。DMTS组恢复呼吸时间12.0±10.4分钟,3例存活对照为22.9±7.0分钟;给药后血乳酸DMTS组5.47±2.65 mmol/L,对照组9.39±4.51 mmol/L(p=0.0310)。5例DMTS存活7天的动物无死亡、无注射部位肌肉损伤组织学证据、无不良神经行为结局。
要点
- 在猪氰化物中毒模型中,呼吸停止后5分钟肌注水溶性DMTS,生存率90%(11例中10例存活),对照组30%(10例中3例存活),p=0.0034。
- DMTS组恢复自主呼吸时间为12.0±10.4分钟(mean±SD),3例存活对照为22.9±7.0分钟(mean±SD)。
- 给药后血乳酸DMTS组为5.47±2.65 mmol/L,对照组为9.39±4.51 mmol/L(mean±SD,p=0.0310)。
- 5例DMTS存活7天的动物无死亡、无注射部位肌肉损伤组织学证据、无观察到的不良神经行为结局。
- 血中仅检测到低浓度DMTS,随时间逐渐升高,未观察到消除相。
适用人群与场景
- 麻醉猪模型,经静脉输注氰化钾直至呼吸停止后5分钟开始治疗;非人类临床人群。
诊断标准与关键阈值
- 氰化物中毒模型标准:静脉输注氰化钾直至呼吸停止后5分钟。
处置流程与药物剂量
- 第一步:静脉输注氰化钾直至呼吸停止后5分钟。
- 第二步:肌注水溶性DMTS(n=11)或生理盐水对照(n=10);原文未提及DMTS剂量、浓度、注射体积和频次。
- 第三步:连续监测生理参数和实验室指标直至实验结束或死亡;亚组(n=5)存活7天评估肌肉完整性和神经行为结局。
红旗征与不能漏的情况
- 原文未提及
研究设计与关键结果
- 研究类型:动物实验(猪模型),单中心,样本量DMTS组n=11、生理盐水对照组n=10。
- 主要终点生存率:DMTS组90% vs 对照组30%(p=0.0034)。
- 恢复呼吸时间:DMTS组12.0±10.4 min vs 3例存活对照22.9±7.0 min(mean±SD)。
- 血乳酸:DMTS组5.47±2.65 mmol/L vs 对照组9.39±4.51 mmol/L(mean±SD,p=0.0310)。
- 药代动力学:血中DMTS浓度低,随时间逐渐升高,未观察到消除相。
- 7天亚组(n=5):无死亡、无注射部位肌肉损伤组织学证据、无观察到的不良神经行为结局。
证据类型、等级与局限
- 证据类型:动物实验(猪模型)。
- 局限性:动物模型,非人类临床研究;样本量小(DMTS组n=11、对照组n=10);单中心;原文未提及剂量-效应关系。
对床旁实践的改变
- 原文结果为动物模型证据,不能直接改变急诊/ICU临床实践;DMTS尚未在人类中验证。
- 适用人群:原文仅限猪氰化物中毒模型;不适用于人类临床决策。
- 常见陷阱:不能将动物模型生存率数据外推为人类推荐;原文未提供DMTS人体剂量。
指南或共识出处
- 原文未提及
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Cyanide is a rapid acting, lethal, metabolic poison and remains a significant threat. Current FDA-approved antidotes are not amenable or efficient enough for a mass casualty incident.
OBJECTIVE: The objective of this study is to evaluate short and long-term efficacy of intramuscular aqueous dimethyl trisulfide (DMTS) on survival and clinical outcomes in a swine model of cyanide exposure.
METHODS: Anesthetized swine were instrumented and acclimated until breathing spontaneously. Potassium cyanide infusion was initiated and continued until 5 min after the onset of apnea. Subsequently, animals were treated with intramuscular DMTS (n = 11) or saline control (n = 10). Laboratory values and DMTS blood concentrations were assessed at various time points and physiological parameters were monitored continuously until the end of the experiment unless death occurred. A subset of animals treated with DMTS (n = 5) were survived for 7 days to evaluate muscle integrity by repeat biopsy and neurobehavioral outcomes.
RESULTS: Physiological parameters and time to apnea were similar in both groups at baseline and at time of treatment. Survival in the DMTS-treated group was 90% and 30% in saline controls (p = 0.0034). DMTS-treated animals returned to breathing at 12.0 ± 10.4 min (mean ± SD) compared to 22.9 ± 7.0 min (mean ± SD) in the 3 surviving controls. Blood collected prior to euthanasia showed improved blood lactate concentrations in the DMTS treatment group; 5.47 ± 2.65 mmol/L vs. 9.39 ± 4.51 mmol/L (mean ± SD) in controls (p = 0.0310). Low concentrations of DMTS were detected in the blood, gradually increasing over time with no elimination phase observed. There was no mortality, histological evidence of muscle trauma, or observed adverse neurobehavioral outcomes, in DMTS-treated animals survived to 7 days.
CONCLUSION: Intramuscular administration of aqueous DMTS improves survival following cyanide poisoning with no observed long-term effects on muscle integrity at the injection site or adverse neurobehavioral outcomes.
参考来源
- Hendry-Hofer TB, Severance CC, Bhadra S, et al. Evaluation of aqueous dimethyl trisulfide as an antidote to a highly lethal cyanide poisoning in a large swine model. Clin Toxicol (Phila). 2021. PMID: 34142637. doi:10.1080/15563650.2021.1935992
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。